BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lymphoma AND CACNA1D, CCHL1A2, Cav1_3, CACNL1A2, CACN4, CACH3, ENSG00000157388, 776 AND Treatment
25 results:

  • 1. Identification of risk factors and prediction models for secondary malignant neoplasms (SMNs)-free survival and SMNs-specific survival in testicular cancer survivors.
    Fu H; Talluri S; Rai S; Liang L; Trivedi J; Ankem MK
    World J Urol; 2023 Sep; 41(9):2413-2420. PubMed ID: 37530808
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Detecting the expression of HRs and BCL2 via IHC can help identify luminal A-like subtypes of triple-positive breast cancers.
    Xu Y; Liang Y; Yin G
    Clin Transl Oncol; 2023 Apr; 25(4):1024-1032. PubMed ID: 36376700
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. The efficacy and cardiac toxicity of different-dose pegylated liposomal doxorubicin in elderly patients with diffuse large B lymphoma.
    Li L; Chen R; Zhou D; Sun J; Wang L; Zhu L; Shen H; Xie W; Ye X
    Cancer Med; 2023 Feb; 12(4):4184-4194. PubMed ID: 36200320
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Length of Stay and Health Care Utilization Among Pediatric Autologous Hematopoietic Cell Transplantation Recipients.
    Davis L; Yao Y; Jin Z; Moscoso S; Neunert C; Broglie L; Hall M; Bhatia M; George D; Garvin JH; Satwani P
    Transplant Cell Ther; 2021 Jul; 27(7):613.e1-613.e7. PubMed ID: 33831624
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Cancer Stage, treatment, and Survival Among Transgender Patients in the United States.
    Jackson SS; Han X; Mao Z; Nogueira L; Suneja G; Jemal A; Shiels MS
    J Natl Cancer Inst; 2021 Sep; 113(9):1221-1227. PubMed ID: 33704460
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. treatment with intravenous busulfan, melphalan, and etoposide followed by autologous stem cell transplantation in patients with non-Hodgkin's lymphoma: a multicenter study from the consortium for improving survival of lymphoma.
    Kim KH; Kim WS; Kim SJ; Yoon DH; Suh C; Kang HJ; Choi CW; Lee HS; Bae SH; Park J; Park EK; Kwak JY; Lee MH; Kang BW; Park SK; Won JH
    Transpl Int; 2020 Oct; 33(10):1211-1219. PubMed ID: 32479690
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Spectrum of malignancies among the population of adults living with HIV infection in China: A nationwide follow-up study, 2008-2011.
    Zhu W; Mao Y; Tang H; McGoogan JM; Zhang ZF; Detels R; He N; Wu Z
    PLoS One; 2019; 14(7):e0219766. PubMed ID: 31344059
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Sepsis and Acute Myeloid Leukemia: A Population-Level Study of Comparative Outcomes of Patients Discharged From Texas Hospitals.
    Malik IA; Cardenas-Turanzas M; Gaeta S; Borthakur G; Price K; Cortes J; Nates JL
    Clin Lymphoma Myeloma Leuk; 2017 Dec; 17(12):e27-e32. PubMed ID: 28844403
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Whole-exome and transcriptome sequencing of refractory diffuse large B-cell lymphoma.
    Park HY; Lee SB; Yoo HY; Kim SJ; Kim WS; Kim JI; Ko YH
    Oncotarget; 2016 Dec; 7(52):86433-86445. PubMed ID: 27835906
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Childhood cancer survival in Switzerland (1976-2013): Time-trends and predictors.
    Schindler M; Belle FN; Grotzer MA; von der Weid NX; Kuehni CE;
    Int J Cancer; 2017 Jan; 140(1):62-74. PubMed ID: 27632765
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. [Clinicopathological characteristics and prognostic analysis of primary intestinal diffuse large B-cell lymphoma].
    Huang Y; Zhou S; He X; Gui L; Yang J; Liu P; Qin Y; Zhang C; Xing P; Yang S; Wang L; Zhou L; Dong M; Sun Y; Shi Y
    Zhonghua Yi Xue Za Zhi; 2015 Dec; 95(48):3895-8. PubMed ID: 27122208
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. [A collaborative study of children with lymphoblastic non-Hodgkin's lymphoma in China].
    ;
    Zhonghua Er Ke Za Zhi; 2015 Dec; 53(12):931-7. PubMed ID: 26887549
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Incidental diagnosis of tumor thrombosis on FDG PET/CT imaging.
    Erhamamci S; Reyhan M; Nursal GN; Torun N; Yapar AF
    Rev Esp Med Nucl Imagen Mol; 2015; 34(5):287-94. PubMed ID: 26025479
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Prognostic value of interim FDG-PET in Hodgkin lymphoma: systematic review and meta-analysis.
    Adams HJ; Nievelstein RA; Kwee TC
    Br J Haematol; 2015 Aug; 170(3):356-66. PubMed ID: 25868485
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Clinical utility of sequential minimal residual disease measurements in the context of risk-based therapy in childhood acute lymphoblastic leukaemia: a prospective study.
    Pui CH; Pei D; Coustan-Smith E; Jeha S; Cheng C; Bowman WP; Sandlund JT; Ribeiro RC; Rubnitz JE; Inaba H; Bhojwani D; Gruber TA; Leung WH; Downing JR; Evans WE; Relling MV; Campana D
    Lancet Oncol; 2015 Apr; 16(4):465-74. PubMed ID: 25800893
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. A retrospective analysis of clinicopathological characteristics, treatment, and outcome of 27 patients of primary intestinal lymphomas.
    Khosla D; Kumar R; Kapoor R; Kumar N; Bera A; Sharma SC
    J Gastrointest Cancer; 2013 Dec; 44(4):417-21. PubMed ID: 23820932
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. The effect of HAART and calendar period on Kaposi's sarcoma and non-Hodgkin lymphoma: results of a match between an AIDS and cancer registry.
    Pipkin S; Scheer S; Okeigwe I; Schwarcz S; Harris DH; Hessol NA
    AIDS; 2011 Feb; 25(4):463-71. PubMed ID: 21139489
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Unresectable chemorefractory liver metastases: radioembolization with 90Y microspheres--safety, efficacy, and survival.
    Sato KT; Lewandowski RJ; Mulcahy MF; Atassi B; Ryu RK; Gates VL; Nemcek AA; Barakat O; Benson A; Mandal R; Talamonti M; Wong CY; Miller FH; Newman SB; Shaw JM; Thurston KG; Omary RA; Salem R
    Radiology; 2008 May; 247(2):507-15. PubMed ID: 18349311
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Recent cancer survival in Europe: a 2000-02 period analysis of EUROCARE-4 data.
    Verdecchia A; Francisci S; Brenner H; Gatta G; Micheli A; Mangone L; Kunkler I;
    Lancet Oncol; 2007 Sep; 8(9):784-96. PubMed ID: 17714993
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Definition of subtypes of essential thrombocythaemia and relation to polycythaemia vera based on JAK2 V617F mutation status: a prospective study.
    Campbell PJ; Scott LM; Buck G; Wheatley K; East CL; Marsden JT; Duffy A; Boyd EM; Bench AJ; Scott MA; Vassiliou GS; Milligan DW; Smith SR; Erber WN; Bareford D; Wilkins BS; Reilly JT; Harrison CN; Green AR; ; ;
    Lancet; 2005 Dec; 366(9501):1945-53. PubMed ID: 16325696
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.